REGENERON PHARMACEUTICALS, INC. (REGN)
Clinical trial NCT06161441 updates: 1. primary completion date: 2026-04-17 → 2026-04-20 2. enrollment: not set → 195 participants
Clinical trial NCT06161441 updates: 1. primary completion date: 2026-04-17 → 2026-04-20 2. enrollment: not set → 195 participants
📉 **NEGATIVE** • Medium confidence analysis (64%) • Mild negative clinical indicator • Limited downside risk **Sentiment:** Negative (23%) **Content type:** Clinical